CINCOR PHARMA INC (CINC) Forecast, Price Target & Analyst Ratings

NASDAQ:CINC • US17240Y1091

Current stock price

29.06 USD
-0.14 (-0.48%)
At close:
29.25 USD
+0.19 (+0.65%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CINCOR PHARMA INC (CINC).

Forecast Snapshot

Consensus Price Target

Price Target
$39.78
+ 36.89% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2022
EPS Estimate
-$0.59
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$39.78
Upside
+ 36.89%
From current price of $29.06 to mean target of $39.78, Based on 12 analyst forecasts
Low
$30.30
Median
$31.62
High
$55.65

Price Target Revisions

1 Month
0.00%
3 Months
-3.94%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for CINC. The average price target is 39.78 USD. This implies a price increase of 36.89% is expected in the next year compared to the current price of 29.06.
The average price target has been revised downward by 3.94% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CINC Current Analyst RatingCINC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

CINC Historical Analyst RatingsCINC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
78.33%
CINC was analyzed by 12 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CINC.
In the previous month the buy percentage consensus was at a similar level.
CINC was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-01-12BarclaysDowngrade Overweight -> Equal-Weight
2023-01-10Morgan StanleyMaintains Equal-Weight
2022-12-08BarclaysInitiate Overweight
2022-12-07BarclaysInitiate Overweight
2022-11-29OppenheimerDowngrade Outperform -> Perform
2022-11-29Morgan StanleyDowngrade Overweight -> Equal-Weight
2022-10-28Goldman SachsInitiate Buy
2022-09-09Morgan StanleyMaintains Overweight
2022-08-22Piper SandlerInitiate Overweight
2022-08-09Morgan StanleyMaintains Overweight
2022-07-21OppenheimerMaintains Outperform
2022-07-15Morgan StanleyMaintains Overweight
2022-02-01OppenheimerInitiate Outperform
2022-02-01Evercore ISI GroupInitiate Outperform
2022-02-01Morgan StanleyInitiate Overweight
2022-02-01JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2022
EPS Estimate
-$0.59
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
96.25%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-3.99%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
CINC revenue by date.CINC revenue by date.
N/AN/AN/AN/AN/AN/A
166.49%		N/A
15.29%		N/A
14.89%		N/A
17.13%
EBITDA
YoY % growth
CINC ebitda by date.CINC ebitda by date.
N/AN/AN/AN/A
42.74%		N/A
-29.17%		N/A
-19.05%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CINC ebit by date.CINC ebit by date.
-5.137M-21.125M
-311.26%		-42.51M
-101.23%		N/A
-28.10%		N/A
-36.10%		N/A
-11.64%		N/A
-116.69%		N/A
331.83%		N/A
242.35%		N/A
16.37%		N/A
16.12%		N/A
19.34%
Operating Margin
CINC operating margin by date.CINC operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CINC eps by date.CINC eps by date.
N/AN/AN/AN/A
72.63%		N/A
-16.06%		N/A
-14.13%		N/A
-35.28%		N/A
313.99%		N/A
107.02%		N/A
15.20%		N/A
15.63%		N/A
18.70%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.59
96.25%		-0.56
-11.38%		-0.60
-7.46%		-0.64
-26.40%		-0.77
-31.25%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-25.188M
0.17%		-25.965M
-89.46%		-28.236M
-32.24%		-30.513M
-37.17%		-34.974M
-38.85%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CINC Yearly Revenue VS EstimatesCINC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
CINC Yearly EPS VS EstimatesCINC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 10 20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
17.87%
EPS Next 5 Year
24.98%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-8.54%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CINCOR PHARMA INC / CINC Forecast FAQ

Can you provide the average price target for CINCOR PHARMA INC stock?

12 analysts have analysed CINC and the average price target is 39.78 USD. This implies a price increase of 36.89% is expected in the next year compared to the current price of 29.06.

What are the consensus estimates for CINCOR PHARMA INC (CINC) next earnings?

The consensus EPS estimate for the next earnings of CINCOR PHARMA INC (CINC) is -0.59 USD and the consensus revenue estimate is 0 USD.